Randomized trial of care management to improve Parkinson disease care quality
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 9, 2018
- Accepted in final form December 26, 2018
- First Published March 22, 2019.
Article Versions
- Previous version (March 22, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Karen I. Connor, PhD, RN, MBA,
- Eric M. Cheng, MD, MS,
- Frances Barry, MA,
- Hilary C. Siebens, MD,
- Martin L. Lee, PhD,
- David A. Ganz, MD, PhD,
- Brian S. Mittman, PhD,
- Megan K. Connor, RN, MSN, MPH,
- Lisa K. Edwards, BA,
- Michael G. McGowan, MA and
- Barbara G. Vickrey, MD, MPH
- Karen I. Connor, PhD, RN, MBA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Veteran Affairs, VA HSR&D-NRI 11-126, Principal Investigator, 2012- 2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eric M. Cheng, MD, MS,
NONE
NONE
American Academy of Neurology, funding for travel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH/NHLBI, R01 HL114563, 2013-2018 (2) NIH/NINDS U54 NS081764 02S1 supplement, PI, 2013- 2018
NONE
(1) National Multiple Sclerosis Society (HC 0128)
NONE
NONE
NONE
NONE
NONE
NONE
- Frances Barry, MA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hilary C. Siebens, MD,
NONE
NONE
NONE
NONE
NONE
Siebens Health Care Notebook 2008, Siebens Patient Care Communications
Siebens Patient Care Communications, Principal 2005-2016 Siebens Patient Care Communications LLC, Principal 2017 -
Department of Veterans Affairs
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Siebens Domain Management ModelTM, Department of Veterans Affairs
NONE
NONE
NONE
NONE
- Martin L. Lee, PhD,
Viking Therapeutics, commercial biotech
NONE
NONE
NONE
Testing of human milk
NONE
Prolacta Bioscience, VP, Clinical R&D, 2001-present
Catalyst Bioscience, commercial biotech
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David A. Ganz, MD, PhD,
NONE
NONE
NONE
Journal of the American Geriatrics Society, Section Editor, 2012-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Department of Veterans Affairs Quality Enhancement Research Initiative, QUE 15-276, Principal Investigator, 2015-present; National Institute on Aging, 5U01AG048270- 05, Co-investigator, 2014-present; National Institute of Neurological Disorders and Stroke, 5U54NS081764-06, Co- investigator, 2012-present.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brian S. Mittman, PhD,
(1) National Institute on Drug Abuse Clinical Trials Network DSMB
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Merck Vaccines Division Speakers' Bureau
NONE
NONE
NONE
(1) AHRQ, 1R13HS026680-01, PI, 2018-2019, (2) NIH/NIDCR, 5U01DE027452-02, co-I, 2017-2022, (3) NIH/NHLBI, 1U01HL142104-01, co-I 2018-2022, (4) Health Resources and Services Administration, R390T29879-01, co-I, 2016-2019, (5) Patient-Centered Outcomes Research Institute, TC-1403-14049, co-PI, 2015-2019, (6) Patient-Centered Outcomes Research Institute, PCS-1403-12653, co-I, 2015-2020, (7) Patient- Centered Outcomes Research Institute, PLC-1609-36108, co-I, 2018-2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Megan K. Connor, RN, MSN, MPH,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Veterans Affairs, VA HSR&D-NRI 11-126, medical record abstractor, 2016, 2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lisa K. Edwards, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael G. McGowan, MA and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Barbara G. Vickrey, MD, MPH
(1) NIA-funded study, CHOICE (Indiana University), Data Safety and Monitoring Board, 2012-2018 (2) NIA-funded study, COADS (Indiana University), Data Safety and Monitoring Board, 2018-present
NONE
(1) American Neurological Association - funding for travel (2) American Academy of Neurology - funding for travel
NONE
NONE
NONE
NONE
NONE
NONE
Steering Committee, California Stroke Registry/California Coverdell Program for California Department of Public Health (unpaid)
NONE
NONE
NINDS/NIH, U54 NS081764, PI, 2012-present
NONE
California Community Foundation, PI of grant
NONE
NONE
NONE
NONE
NONE
NONE
- From the Veterans Affairs Greater Los Angeles Parkinson's Disease Research, Education and Clinical Center (K.I.C., L.K.E., M.G.M.); University of California Los Angeles David Geffen School of Medicine (K.I.C., E.M.C., F.B.); Siebens Patient Care Communications LLC (H.C.S.), Seal Beach; Veterans Affairs Sepulveda Ambulatory Care Center (M.L.L.), North Hills; University of California Los Angeles Fielding School of Public Health (M.L.L.); Veterans Affairs Geriatric Research, Education and Clinical Center and Center for the Study of Healthcare Innovation, Implementation and Policy (D.A.G.), Los Angeles; Kaiser Permanente Research (B.S.M.), Pasadena; University of California San Francisco (M.K.C.); and Icahn School of Medicine at Mount Sinai (B.G.V.), New York, NY.
- Correspondence
Dr. Connor kiconnor{at}ucla.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A. Beck, Denise B. Beran, Kevin M. Biglan et al.Neurology, August 16, 2017 -
Editorial
A nurse-led model increases quality of care in Parkinson diseasePaolo Calabresi, Pasquale Nigro, Heidi Beck Schwarz et al.Neurology, March 22, 2019 -
Articles
MS quality of life, depression, and fatigue improve after mindfulness trainingA randomized trialP. Grossman, L. Kappos, H. Gensicke et al.Neurology, September 27, 2010 -
Research
High patient satisfaction with telehealth in Parkinson diseaseA randomized controlled studyJayne R. Wilkinson, Meredith Spindler, Stephanie M. Wood et al.Neurology: Clinical Practice, May 03, 2016